IRIS
LANDI, DORIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.131
EU - Europa 914
AS - Asia 578
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 3
OC - Oceania 3
Totale 6.647
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.124
IT - Italia 391
SG - Singapore 288
IE - Irlanda 229
KR - Corea 179
CN - Cina 70
DE - Germania 70
GB - Regno Unito 56
RU - Federazione Russa 40
UA - Ucraina 33
SE - Svezia 23
FR - Francia 18
FI - Finlandia 14
CZ - Repubblica Ceca 10
IN - India 10
JP - Giappone 10
CH - Svizzera 9
CA - Canada 7
GR - Grecia 6
PL - Polonia 5
CL - Cile 4
ES - Italia 4
AR - Argentina 3
BR - Brasile 3
CO - Colombia 3
EU - Europa 3
IQ - Iraq 3
RO - Romania 3
UZ - Uzbekistan 3
AU - Australia 2
HK - Hong Kong 2
IR - Iran 2
KG - Kirghizistan 2
NG - Nigeria 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
ID - Indonesia 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MY - Malesia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 6.647
Salva come PNG Salva come JPEG
Città #
Wilmington 1.377
Houston 1.102
Woodbridge 642
New York 403
Chandler 258
Singapore 250
Fairfield 212
Dublin 210
Ashburn 87
Rome 85
Ann Arbor 71
Roebling 71
Medford 68
Seattle 65
Cambridge 59
Santa Clara 56
Lawrence 33
Moscow 33
Beijing 31
Dearborn 29
San Jose 25
San Diego 22
Milan 21
Creede 19
Jacksonville 18
Piove di Sacco 16
London 14
Mülheim 12
Seoul 12
Palo Alto 11
Turin 11
Brno 10
Los Angeles 9
Naples 9
Norwalk 9
Inverigo 8
Redwood City 8
Boardman 7
Kilburn 7
Lodi 7
Munich 7
Zhengzhou 7
Florence 6
Nanjing 6
Billings 5
Helsinki 5
Hounslow 5
Palermo 5
Tokyo 5
Atlanta 4
Chiswick 4
Frankfurt am Main 4
Kunming 4
Lausanne 4
Nuremberg 4
Saitama 4
San Francisco 4
Schio 4
Xi'an 4
Bergamo 3
Bogotá 3
Bologna 3
Chennai 3
Detroit 3
Falls Church 3
Guangzhou 3
Karbala 3
Kraków 3
Lappeenranta 3
Menlo Park 3
Paris 3
Philadelphia 3
Salo 3
Abuja 2
Athens 2
Bad Bruckenau 2
Basel 2
Bogliasco 2
Brooklyn 2
Campi Bisenzio 2
Cardano al Campo 2
Carugate 2
Changsha 2
Copertino 2
Del Norte 2
Edmond 2
Essen 2
Formia 2
Gunzenhausen 2
Hangzhou 2
Hawkestone Beach 2
Islington 2
La Spezia 2
Lissone 2
Macerata 2
Minneapolis 2
Minturno 2
Montemesola 2
Mountain View 2
New Westminster 2
Totale 5.584
Salva come PNG Salva come JPEG
Nome #
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 449
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 433
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression 398
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 385
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 299
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 294
null 289
Safety, tolerability and effectiveness of dimethyl fumarate in multiple sclerosis: an independent, multicenter, real-world study 285
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 278
Miscarriage induces reactivation of inflammation in relapsing-remitting multiple sclerosis 275
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 272
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study 261
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 163
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis 154
Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study 126
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis 115
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab 90
Functional assessment of outer and middle macular layers in multiple sclerosis 90
Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 73
Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy 72
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 64
Correction to: Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 62
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 61
Assessment of macular function by multifocal electroretinogram in patients with multiple sclerosis treated with fingolimod 61
Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis 60
T-cell responses to SARS-CoV-2 in Multiple Sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-Spike antibody titers 51
B- and T-Cell Responses After {SARS}-{CoV}-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 51
Anti-HBs titers are not decreased after treatment with oral cladribine in patients with multiple sclerosis vaccinated against hepatitis B virus 51
Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey 45
Exposure to natalizumab during pregnancy and lactation is safe - Yes 44
COVID-19: dealing with a potential risk factor for chronic neurological disorders 44
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 42
Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis 39
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection 39
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 37
Cognition is related to resting-state small-world network topology: an magnetoencephalographic study 36
What happens after fingolimod discontinuation? A multicentre real-life experience 36
Cortical ischemic lesion burden measured by DIR is related to carotid artery disease severity 35
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 34
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 34
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population 33
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab 33
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 32
Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment 31
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis 31
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 30
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study 29
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 29
Anti-HBs titers are not decreased after treatment with oral Cladribine in patients with Multiple Sclerosis vaccinated against Hepatitis B virus 28
Functional Assessment of Outer and Middle Macular Layers in Multiple Sclerosis 28
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression 27
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis 26
Complex epileptic palilalia: a case report 26
Executive functioning in relapsing-remitting multiple sclerosis patients without cognitive impairment: A task-switching protocol 25
Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment 25
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 25
Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells' Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration 25
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 24
Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability 24
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 24
Diffusion-weighted lesions after carotid artery stenting are associated with cognitive impairment 24
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 22
Cortico-muscular coherence as an index of fatigue in multiple sclerosis 22
Sex effects across the lifespan in women with multiple sclerosis 22
Intra-cortical connectivity in multiple sclerosis: a neurophysiological approach 21
Ovarian reserve in patients with multiple sclerosis: A systematic review and meta-analysis 21
Choriocapillaris Integrity in Relapsed Central Serous Chorioretinopathy in a Patient Treated With Fingolimod for Multiple Sclerosis: New Insights From Optical Coherence Tomography Angiography 21
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 21
A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients 20
fMRI-vs-MEG evaluation of post-stroke interhemispheric asymmetries in primary sensorimotor hand areas 20
Do we have enough evidence for recommending therapeutic apheresis for natalizumab-related progressive multifocal leukoencephalopathy patients? Comment on "Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for apheresis: The seventh special issue." 20
Skin Thickening of the Scalp and High Signal Intensity of Dentate Nucleus in Multiple Sclerosis: Association With Linear Versus Macrocyclic Gadolinium-Based Contrast Agents Administration 19
Cerebral restorative plasticity from normal ageing to brain diseases: a "never ending story" 18
COVID-19 vaccine hesitancy among Italian people with multiple sclerosis 18
Dorsolateral medullary ischemic infarction causing autonomic dysfunction and headache: a case report 17
What happens after fingolimod discontinuation? A multicentre real-life experience 17
Gender-related differences in functional connectivity in multiple sclerosis 17
Sars-CoV2 infection in pregnant women with multiple sclerosis 16
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab 16
Functional connectivity changes in multiple sclerosis patients: a graph analytical study of MEG resting state data 16
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 15
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 15
Thalamocortical sensorimotor circuit in multiple sclerosis: an integrated structural and electrophysiological assessment 15
Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing???remitting multiple sclerosis 15
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 15
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 14
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis 14
Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis 12
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop) 12
Optimizing the "Time to pregnancy" in women with multiple sclerosis: the OPTIMUS Delphi survey 12
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT) 11
Sars-CoV2 infection in pregnant women with multiple sclerosis 9
Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy 8
Exposure to natalizumab during pregnancy and lactation is safe - Yes 8
Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy 7
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience 6
null 5
null 3
Do we have enough evidence for recommending therapeutic apheresis for natalizumab-related progressive multifocal leukoencephalopathy patients? Comment on "Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for apheresis: The seventh special issue." 1
Totale 6.867
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.879
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.160 0 0 82 114 98 142 132 118 144 124 99 107
2020/20211.140 100 117 112 117 155 132 157 123 35 41 32 19
2021/2022442 37 30 20 40 25 51 25 24 43 36 24 87
2022/20231.362 52 35 340 228 69 212 151 74 93 12 70 26
2023/2024538 121 10 28 29 40 79 39 14 31 23 14 110
2024/2025537 73 456 8 0 0 0 0 0 0 0 0 0
Totale 6.867